🇺🇸 PTGX — Protagonist Therapeutics, Inc.

Salud Compra fuerte
← Volver

Precio actual

140,24 USD

Máx. histórico

158,62

78 días

Caída desde máximo

-11,59%

Rango 52 semanas

75,44 – 160,81

Variación hoy

+0,62%

Cierre anterior

139,37

Rango de hoy

139,91 – 144,27

Volumen hoy

673.087

Peor caída histórica

-85,79%

01/09/2021 → 13/06/2022

Recuperado en 1001 días

Volatilidad anualizada ⓘ

89,34%

Información
Nombre completo
Protagonist Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
141
PER ⓘ
136,16 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
178,57 USD (puede no estar actualizado)
Primera cotización
11/08/2016
Precio actualizado
hace 23 horas
Sobre la empresa

Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States. It develops Icotyde, a first-in-class investigational targeted oral peptide for the treatment of adults and pediatric patients 12 years of age and older with moderate-to-severe plaque psoriasis; and Rusfertide, a first-in-class investigational injectable mimetic of the natural hormone hepcidin in Phase 3 development for the treatment of the rare blood disorder polycythemia vera. The company is also developing PN-881, a potential best-in-class oral peptide IL-17 antagonist, for the treatment of immune-mediated skin diseases in Phase 1 clinical trials; PN-477 and PN-458, which are development candidates for the treatment of obesity; PN-8047, an orally administered hepcidin functional mimetic small molecule; L-4R alpha antagonist for the treatment of atopic dermatitis and moderate-to-severe asthma; and amylinR-based oral and subcutaneous mono- and poly-agonists for the treatment of obesity. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
03/04/2023 23,00 23,91 22,74 22,82 -0,78% 5,09% 733.800
31/03/2023 22,61 23,15 22,37 23,00 +2,27% 3,45% 1.092.200
30/03/2023 22,39 23,15 22,10 22,49 +0,67% 4,71% 901.500
29/03/2023 21,21 22,38 20,85 22,34 +6,28% 7,21% 731.800
28/03/2023 21,67 21,81 21,00 21,02 -3,40% 3,74% 588.200
27/03/2023 20,87 21,77 20,45 21,76 +4,97% 6,30% 628.000
24/03/2023 20,74 21,02 20,41 20,73 -1,33% 2,92% 933.100
23/03/2023 21,25 21,41 20,39 21,01 -0,14% 4,80% 840.500
22/03/2023 22,71 22,71 21,00 21,04 -7,48% 7,53% 999.400
21/03/2023 22,71 23,14 21,91 22,74 -0,18% 5,42% 1.023.400
20/03/2023 22,75 23,65 22,30 22,78 +1,61% 5,93% 1.147.700
17/03/2023 23,15 23,44 22,38 22,42 -3,15% 4,58% 3.251.000
16/03/2023 24,00 24,00 21,42 23,15 -3,74% 10,75% 1.889.700
15/03/2023 24,80 25,41 23,87 24,05 -4,87% 6,21% 1.677.300
14/03/2023 25,53 25,69 24,76 25,28 -0,39% 3,66% 1.755.400
13/03/2023 24,14 25,64 23,51 25,38 +1,52% 8,82% 2.868.900
10/03/2023 24,35 25,38 23,09 25,00 +2,92% 9,40% 4.704.800
09/03/2023 24,16 25,55 23,92 24,29 +0,73% 6,75% 2.479.700
08/03/2023 23,16 24,30 22,47 24,12 +4,44% 7,90% 5.083.400
07/03/2023 16,97 23,69 16,71 23,09 +51,91% 41,12% 22.971.500
06/03/2023 15,71 15,71 15,01 15,20 -3,25% 4,46% 566.800
03/03/2023 15,56 16,06 15,45 15,71 +1,62% 3,92% 572.100
02/03/2023 15,46 15,69 15,24 15,46 -1,21% 2,91% 1.276.600
01/03/2023 16,22 16,53 15,57 15,65 -3,51% 5,95% 883.800
28/02/2023 16,01 16,33 15,76 16,22 -0,31% 3,56% 915.600
27/02/2023 16,98 17,38 16,17 16,27 -3,56% 7,13% 1.328.300
24/02/2023 16,10 17,28 15,94 16,87 +3,88% 8,32% 2.288.300
23/02/2023 16,00 16,26 15,66 16,24 +2,72% 3,74% 2.192.900
22/02/2023 15,83 16,25 15,72 15,81 +0,44% 3,35% 687.500
21/02/2023 15,90 16,38 15,53 15,74 -2,66% 5,37% 779.400